Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography.
An analytical HPLC method is reported for simultaneous measurement of low (1.0-100 microg ml(-1)) concentrations of dextran-methylprednisolone succinate (DEX-MPS) and its degradation products methylprednisolone hemisuccinate (MPS) and methylprednisolone (MP). The analytes were detected at 250 nm after resolution using a size exclusion column with a mobile phase of KH2PO4 (10 mM): acetonitrile (3:1) and a flow rate of 1 ml min(-1). The resolution of MP and MPS peaks was substantially affected by the pH of the mobile phase; while MP and MPS co-eluted at pH 3.4, they were baseline-resolved at pH > or = 5. Linear relationships (r > or = 0.997) were found between the detector response and the concentrations of the analytes (1.0-100 microg ml(-1) for MP and MPS and 2.5-100 microg ml(-1) for DEX-MPS). Intra- and inter-run error (< 13%) and precision (CV of < or = 6%) data indicated that the assay could accurately and precisely quantitate all three components in the examined concentration range. The application of the assay to determination of degree of substitution, purity, and stability of DEX-MPS was also demonstrated.
Mehvar
R
R
College of Pharmacy and Health Sciences, Drake University, Des Moines, IA 50311, USA. reza.mehvar@drake.edu
D000893:Anti-Inflammatory Agents / Q000032:analysis*; D002138:Calibration; D002850:Chromatography, Gel; D003911:Dextrans / Q000032:analysis*; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D008775:Methylprednisolone / Q000032:analysis*; D008776:Methylprednisolone Hemisuccinate / Q000032:analysis*; D008970:Molecular Weight; D015203:Reproducibility of Results; D012996:Solutions
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D012996:Solutions; D008776:Methylprednisolone Hemisuccinate; D008775:Methylprednisolone